Virtus LifeSci Biotech Clinical Trials ETF
14 hedge funds and large institutions have $9.72M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$3.36M |
2 |
2
LPL Financial
San Diego,
California
|
$1.28M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$234K |
4 |
4
Morgan Stanley
New York
|
$217K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$37K |